Social environmental stressors, psychological factors, and kidney disease
- PMID: 19240646
- PMCID: PMC2824501
- DOI: 10.2310/JIM.0b013e31819dbb91
Social environmental stressors, psychological factors, and kidney disease
Abstract
Kidney disease is one of the most striking examples of health disparities in American public health. Disparities in the prevalence and progression of kidney disease are generally thought to be a function of group differences in the prevalence of kidney disease risk factors such as diabetes, hypertension, and obesity. However, the presence of these comorbidities does not completely explain the elevated rate of progression from chronic kidney disease (CKD) to end-stage renal disease among high-risk populations such as African Americans. We believe that the social environment is an important element in the pathway from CKD risk factors to CKD and end-stage renal disease. This review of the literature draws heavily from social science and social epidemiology to present a conceptual frame specifying how social, economic, and psychosocial factors interact to affect the risks for and the progression of kidney disease.
Conflict of interest statement
Conflict of Interest: The authors have no financial conflicts of interest.
Figures
References
-
- Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–2047. - PubMed
-
- U.S. Renal Data System. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.
-
- Jamerson KA. Preventing chronic kidney disease in special populations. Am J Hypertens. 2005;18:106S–111S. - PubMed
-
- Hsu C-Y, Lin F, Vittinghoff E, et al. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902–2907. - PubMed
-
- Xue JL, Ma JZ, Louis TA, et al. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001;12:2753–2758. - PubMed
Publication types
MeSH terms
Grants and funding
- 1 K01 HL88735-01/HL/NHLBI NIH HHS/United States
- TL1 RR024978/RR/NCRR NIH HHS/United States
- P20 MD002314/MD/NIMHD NIH HHS/United States
- K01 HL088735/HL/NHLBI NIH HHS/United States
- 1KL2RR024977-01/RR/NCRR NIH HHS/United States
- 1ULRR024975-01/PHS HHS/United States
- N01-HC-95171/HC/NHLBI NIH HHS/United States
- 1UL1RR024975-01/RR/NCRR NIH HHS/United States
- UL1 RR024975/RR/NCRR NIH HHS/United States
- N01 HC095171/HL/NHLBI NIH HHS/United States
- K01 HL084682/HL/NHLBI NIH HHS/United States
- KL2 RR024977/RR/NCRR NIH HHS/United States
- 1TL1RR024978-01/RR/NCRR NIH HHS/United States
- 1 K01 HL084682-01/HL/NHLBI NIH HHS/United States
- 1P20 MD002314-01/MD/NIMHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
